Luteinizing hormone secretion elicited in a ligand-independent activation of progesterone receptor manner at pituitary level in the rat: Differential effect of two selective estrogen receptor modulators

Neuroscience Letters

Volumn 289, Issue 2, 2000, Pages 111-114

  Gonzalez D ^a   Bellido, C ^a   Aguilar, R ^a   Garrido Gracia, J C ^a   Hernandez G ^b   Alonso, R ^b   Sanchez Criado J E ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Luteinizing hormone; Luteinizing hormone releasing hormone; Progesterone receptor; Prolactin; Rat pituitary; RU486; Selective estrogen receptor modulators

Indexed keywords

GONADORELIN; MIFEPRISTONE; PROGESTERONE RECEPTOR; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; HYPOPHYSIS; IN VITRO STUDY; LUTEINIZING HORMONE RELEASE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROLACTIN RELEASE; RAT;

ANIMALS; ESTROGEN RECEPTOR MODULATORS; FEMALE; GONADOTROPIN-RELEASING HORMONE; LUTEINIZING HORMONE; MIFEPRISTONE; PITUITARY GLAND, ANTERIOR; PREGNANCY; PROLACTIN; RALOXIFENE; RATS; RATS, WISTAR; RECEPTORS, PROGESTERONE; TAMOXIFEN;

EID: 0342298592     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01270-2     Document Type: Article

References (20)

1. Aronica S.M., Kraus W.L., Katzenellenbogen B.S. Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc. Natl. Acad. Sci. USA. 91:1994;8517-8521.
2. Auger A.P., Moffat C.A., Blaustein J.D. Progesterone-independent activation of rat brain progestin receptors by reproductive stimuli. Endocrinology. 138:1997;511-514.
3. Baker V.L., Draper M., Paul S., Allerheiligen S., Glant M., Shifren J., Jaffe R.B. Reproductive endocrine and endometrial effects of raloxifene hydrochloride, a selective estrogen receptor modulator, in women with regular menstrual cycles. J. Clin. Endocrinol. Metab. 83:1998;6-13.
4. Barkhem T., Carlson B.O., Nilssson Y., Enmark E., Gustafsson J.-A., Nilsson S. Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists. Mol. Pharmacol. 54:1998;105-112.
5. Baulieu E.E., Mester J. Steroid hormone receptors. DeGroot L.J. Endocrinology. PA 1989;16-39 WB Saunders, Philadelphia.
6. Bellido C., González D., Aguilar R., Sánchez-Criado J.E. Antiprogestins RU486 and ZK299 suppress basal and LHRH-stimulated FSH and LH secretion at pituitary level in the rat in a oestrous cycle-dependent manner. J. Endocrinol. 163:1999;79-85.
7. Bression D., Michard M., Le Dafniet M., Pagesy P., Peillon F. Evidence for a specific estradiol binding site on rat pituitary membranes. Endocrinology. 119:1986;1048-1051.
8. Dannies P.S., Yen P.M., Tashjian A.H. Jr. Antiestrogenic compounds increase prolactine and growth hormone synthesis in clonal strains of rat pituitary cells. Endocrinology. 101:1977;1151-1156.
9. Fox S.R., Harlan R.E., Shivers B.D., Pfaff D.W. Chemical characterization of neuroendocrine targets for progesterone in the female rat brain and pituitary. Neuroendocrinology. 51:1990;276-283.
10. Grese T.A., Sluka J.P., Bryant H.U., Cullinan, Glasebrook A.L., Jones C.D., Matsumoto K., Palkovitz A.D., Sato M., Termine J.D., Winter M.A., Yang N.N., Dodge J.A. Molecular determinants of tissue selectivity in estrogen receptor modulators. Proc. Natl. Acad. Sci. USA. 94:1997;14105-14110.
11. Kedar R.P., Bourne T.H., Powles T.J., Collins W.P., Ashley S.E., Cosgrove D.O., Campbell S. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet. 343:1994;1318-1321.
12. 3 cells. Endocrinology. 140:1999;2651-2658.
13. Morley P., Whitfield J.F., Vanderhyden B.C., Tsang B.K., Schwartz J.L. A new, non-genomic estrogen act ion: the rapid release of intracellular calcium. Endocrinology. 131:1992;1305-1312.
14. Peduto J.C., Mahesh V.B. Effects of progesterone on hypothalamic and plasma LHRH. Neuroendocrinology. 40:1985;238-245.
15. Sánchez-Criado J.E., Bellido C., Tébar M., Ruiz A., González D. The antiprogestin RU486 dissociates LH and FSH secretion in male rats: evidence for direct action at the pituitary level. J. Endocrinol. 160:1999;197-203.
16. Sánchez-Criado J.E., Galiot F., Bellido C., González D., Tébar M. Hypothalamus-pituitary-ovarian axis in cyclic rats lacking progesterone actions. Biol. Reprod. 48:1993;916-925.
17. Sato M., Rippy M.K., Bryant H.U. Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and non-reproductive tissues in ovariectomized rats. FASEB J. 10:1996;905-912.
18. Szabo M., Kilen S.M., Nho S.J., Schwartz N.B. Progesterone receptor A and B messenger ribonucleic acid levels in the anterior pituitary of rats are regulaed by estrogen. Biol. Reprod. 62:2000;95-102.
19. Szabo M., Kilen S.M., Saberi S., Ringstrom S.J., Schwartz N.B. Antiprogestins suppress basal and activin-stimulated follicle-stimulating hormone secretion in an estrogen-dependent manner. Endocrinology. 139:1998;2223-2228.
20. Turgeon J.L., Waring D.W. Activation of the progesterone receptor by the gonadotropin-releasing hormone self-priming signaling pathway. Mol. Endocrinol. 8:1994;860-869.